Drugs / Molar Sodium Lactate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT04141371 Comparator | Feb → May 2022 | acquired aneurysmal subarachnoid hemorrhage | Centre Hospitalier Universitaire de Nice | Terminated | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Molar Sodium Lactate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04141371 ↗ |